US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.

Hetero Labs, Ltd. - Unit III NDC 31722-827-30 D-0594-2018
Class II · Moderate risk Terminated

Ibuprofen Tablets USP

Reason CGMP deviations: Ibuprofen is being recalled in response to previous recall

Spirit Pharmaceuticals, LLC NDC 68210-0800-1 D-0583-2018
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Marksans Pharma Inc. NDC 25000-123-27 D-0240-2018
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Marksans Pharma Inc. NDC 25000-122-28 D-0239-2018
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Marksans Pharma Inc. NDC 25000-121-29 D-0238-2018
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Marksans Pharma Inc. NDC 25000-114-30 D-0237-2018
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Marksans Pharma Inc. NDC 25000-136-20 D-0236-2018
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Marksans Pharma Inc. NDC 25000-117-30 D-0235-2018
Class II · Moderate risk Terminated

Lovastatin Tablets USP

Reason Failed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.

AVKARE Inc. NDC 50268-512-15 D-0222-2018
Class II · Moderate risk Terminated

Earth's Care Eczema Lotion

Reason Microbial Contamination of Non-Sterile Products.

DLC Laboratories, Inc NDC 24286-1569-08 D-0241-2018
Class II · Moderate risk Terminated

Esmolol HCl in all strengths

Reason Lack of sterility assurance.

Pharmedium Services, LLC D-0464-2018